WE HAVE recently reported our experiences with a new antifungal agent, 2-dimethylamino-6-(beta-diethylaminoethoxy) benzothiazole (asterol®) dihydrochloride, in tinea capitis of the anthropophilic type.1 The results of treatment in the 72 patients presented were so gratifying, even in the children whose parents contributed little cooperation, that we have since adopted the use of asterol® dihydrochloride as a routine measure in patients with ringworm of the scalp.
When Stritzler and his associates2 reported their encouraging results with asterol® dihydrochloride in tinea of the glabrous skin and the nails, we decided to extend the evaluation of the new drug to patients with superficial fungous infections other than tinea capitis.
At this writing, we have collected adequate data to report our observations on asterol® dihydrochloride treatment in another group of patients with ringworm of the scalp, in a group with moniliasis, and in one with tinea
EDELSON E, HASKIN AH, Ignatoff WB, Titsworth E. TREATMENT OF SUPERFICIAL MYCOLOGICAL INFECTIONS WITH A NEW ANTIFUNGAL AGENT. AMA Arch Derm Syphilol. 1952;66(2):244–250. doi:10.1001/archderm.1952.01530270102013
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: